GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Sona Nanotech Inc (XCNQ:SONA) » Definitions » Net Cash per Share

Sona Nanotech (XCNQ:SONA) Net Cash per Share : C$0.00 (As of Apr. 2025)


View and export this data going back to 2006. Start your Free Trial

What is Sona Nanotech Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Sona Nanotech's Net Cash per Share for the quarter that ended in Apr. 2025 was C$0.00.

The historical rank and industry rank for Sona Nanotech's Net Cash per Share or its related term are showing as below:

During the past 13 years, the highest Price-to-Net-Cash Ratio of Sona Nanotech was 27.00. The lowest was 27.00. And the median was 27.00.

XCNQ:SONA's Price-to-Net-Cash is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 5.75
* Ranked among companies with meaningful Price-to-Net-Cash only.

Sona Nanotech Net Cash per Share Historical Data

The historical data trend for Sona Nanotech's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sona Nanotech Net Cash per Share Chart

Sona Nanotech Annual Data
Trend Oct14 Oct15 Oct16 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.07 -0.02 -0.01 -0.02 0.01

Sona Nanotech Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.02 0.01 - -

Competitive Comparison of Sona Nanotech's Net Cash per Share

For the Diagnostics & Research subindustry, Sona Nanotech's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sona Nanotech's Price-to-Net-Cash Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sona Nanotech's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Sona Nanotech's Price-to-Net-Cash falls into.


;
;

Sona Nanotech Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Sona Nanotech's Net Cash per Share for the fiscal year that ended in Oct. 2024 is calculated as

Net Cash per Share (A: Oct. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(1.859-1.237-0)/111.720
=0.01

Sona Nanotech's Net Cash per Share for the quarter that ended in Apr. 2025 is calculated as

Net Cash per Share (Q: Apr. 2025 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(0.731-1.279-0)/112.540
=-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sona Nanotech  (XCNQ:SONA) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Sona Nanotech Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Sona Nanotech's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sona Nanotech Business Description

Traded in Other Exchanges
Address
1969 Upper Water Street, Suite 2001, Purdy’s Wharf Tower II, Halifax, NS, CAN, B3J 3R7
Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and various biomedical applications. The company's product includes Gemini and Saliva tests.

Sona Nanotech Headlines

No Headlines